Skip to main content
. 2018 Mar 7;16:51. doi: 10.1186/s12957-018-1332-7

Fig. 2.

Fig. 2

Percentage of ER and PR expression pre- and post-NAC for patients with any receptor conversion. a Percentage of ER expression pre- and post-NAC for patients with any receptor conversion. b Percentage of PR expression pre- and post-NAC for patients with any receptor conversion. (ER estrogen receptor, PR progesterone, NAC neoadjuvant chemotherapy)